This invention relates to substituted indacene molecules that specifically inhibit one or both of the checkpoint kinases Wee1 and Chk1 and are useful in the treatment of proliferative disorders.
这项发明涉及替代的
吲哚烯分子,特异性地抑制检查点激酶Wee1和Chk1中的一个或两个,并在治疗增殖性疾病中有用。